D830030K20Rik Inhibitors
The protein encoded by the gene D830030K20Rik has been implicated in various signaling pathways, and investigating potential inhibitors for this protein sheds light on the intricate regulatory mechanisms that govern its function. While direct inhibitors specifically targeting D830030K20Rik may not be well-established, numerous chemicals with known effects on broader signaling cascades present promising indirect avenues for modulation. Staurosporine, a broad kinase inhibitor, serves as a notable example. By targeting multiple signaling pathways, Staurosporine indirectly influences cellular processes associated with D830030K20Rik. Similarly, LY294002 disrupts the PI3K/AKT pathway, impacting phosphoinositide signaling and potentially affecting D830030K20Rik's function in downstream cellular processes. U0126, an MEK1/2 inhibitor, and PD 98059, an MEK inhibitor, both act upstream of the MAPK pathway, indirectly influencing D830030K20Rik by altering phosphorylation events within the pathway. These inhibitors provide insight into potential regulatory nodes that may impact the protein's function.
The GSK-3 inhibitor SB-216763 and GSK-3 Inhibitor XVI (CHIR-99021) disrupt the glycogen synthase kinase pathway, presenting indirect modulation of D830030K20Rik through altered downstream signaling. Likewise, the JNK inhibitor SP600125 and the selective JNK inhibitor SP0102 target the JNK signaling pathway, suggesting potential impacts on the protein's function through regulation of this pathway. VX-11e, an HDAC inhibitor, introduces an epigenetic regulatory aspect that may indirectly impact D830030K20Rik by influencing chromatin structure and gene expression. Additionally, the mTOR inhibitors, AZD8055 and Wortmannin, present opportunities for indirect modulation by disrupting mTOR signaling and affecting downstream cellular processes. Collectively, these inhibitors provide a diverse set of tools for exploring the regulatory networks involving D830030K20Rik. While their direct impact on the protein may not be fully elucidated, their influence on broader signaling pathways offers valuable insights into potential mechanisms of indirect modulation. Understanding these interactions contributes to a comprehensive view of the cellular processes governed by D830030K20Rik, paving the way for further research into its functional roles and implications in cellular physiology.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
A broad kinase inhibitor, Staurosporine targets multiple signaling pathways, potentially influencing cellular processes associated with D830030K20Rik. By affecting various kinases, it indirectly modulates downstream events, impacting the protein's function. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K inhibitor, LY294002 disrupts the PI3K/AKT pathway, potentially influencing D830030K20Rik through altered phosphoinositide signaling. By affecting key nodes in this pathway, it indirectly modulates the protein's function, impacting cellular processes associated with PI3K/AKT signaling. | ||||||
SB-216763 | 280744-09-4 | sc-200646 sc-200646A | 1 mg 5 mg | $71.00 $202.00 | 18 | |
A GSK-3 inhibitor, SB-216763 disrupts the glycogen synthase kinase pathway, potentially influencing D830030K20Rik through altered downstream signaling. By impacting key regulatory processes, it indirectly modulates the protein's function, impacting cellular processes associated with GSK-3 signaling. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
An MEK inhibitor, PD 98059 targets the MAPK pathway upstream of D830030K20Rik, influencing its activation indirectly. By altering phosphorylation events within the pathway, this inhibitor modulates the protein's function, impacting downstream cellular processes associated with MAPK signaling. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
A PI3K inhibitor, Wortmannin disrupts the PI3K/AKT pathway, potentially influencing D830030K20Rik through altered phosphoinositide signaling. By affecting key nodes in this pathway, it indirectly modulates the protein's function, impacting cellular processes associated with PI3K/AKT signaling. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
A JNK inhibitor, SP600125 targets the JNK signaling pathway upstream of D830030K20Rik, influencing its activation indirectly. By altering phosphorylation events within the pathway, this inhibitor modulates the protein's function, impacting downstream cellular processes associated with JNK signaling. | ||||||
VX-11e | 896720-20-0 | sc-507301 | 10 mg | $180.00 | ||
An HDAC inhibitor, VX-11e modulates epigenetic regulation that may indirectly impact D830030K20Rik. By influencing chromatin structure and gene expression, this inhibitor modulates the protein's function, impacting downstream cellular processes associated with HDAC activity. | ||||||
GSK-3 Inhibitor XVI | 252917-06-9 | sc-221691 sc-221691A | 5 mg 25 mg | $180.00 $610.00 | 4 | |
GSK-3 Inhibitor XVI (CHIR-99021) disrupts the glycogen synthase kinase pathway, potentially influencing D830030K20Rik through altered downstream signaling. By impacting key regulatory processes, it indirectly modulates the protein's function, impacting cellular processes associated with GSK-3 signaling. | ||||||
AZD8055 | 1009298-09-2 | sc-364424 sc-364424A | 10 mg 50 mg | $163.00 $352.00 | 12 | |
A dual mTORC1 and mTORC2 inhibitor, AZD8055 disrupts the mTOR signaling pathway, potentially influencing D830030K20Rik through altered downstream signaling. By impacting key regulatory processes, it indirectly modulates the protein's function, impacting cellular processes associated with mTORC1/2 signaling. | ||||||
GW 5074 | 220904-83-6 | sc-200639 sc-200639A | 5 mg 25 mg | $106.00 $417.00 | 10 | |
A Raf-1 kinase inhibitor, GW5074 targets the Raf/MEK/ERK pathway upstream of D830030K20Rik, influencing its activation indirectly. By altering phosphorylation events within the pathway, this inhibitor modulates the protein's function, impacting downstream cellular processes associated with Raf-1 kinase signaling. | ||||||